Sex-specific genetic predictors of Alzheimer's disease biomarkers
- PMID: 29967939
- PMCID: PMC6280657
- DOI: 10.1007/s00401-018-1881-4
Sex-specific genetic predictors of Alzheimer's disease biomarkers
Abstract
Cerebrospinal fluid (CSF) levels of amyloid-β 42 (Aβ42) and tau have been evaluated as endophenotypes in Alzheimer's disease (AD) genetic studies. Although there are sex differences in AD risk, sex differences have not been evaluated in genetic studies of AD endophenotypes. We performed sex-stratified and sex interaction genetic analyses of CSF biomarkers to identify sex-specific associations. Data came from a previous genome-wide association study (GWAS) of CSF Aβ42 and tau (1527 males, 1509 females). We evaluated sex interactions at previous loci, performed sex-stratified GWAS to identify sex-specific associations, and evaluated sex interactions at sex-specific GWAS loci. We then evaluated sex-specific associations between prefrontal cortex (PFC) gene expression at relevant loci and autopsy measures of plaques and tangles using data from the Religious Orders Study and Rush Memory and Aging Project. In Aβ42, we observed sex interactions at one previous and one novel locus: rs316341 within SERPINB1 (p = 0.04) and rs13115400 near LINC00290 (p = 0.002). These loci showed stronger associations among females (β = - 0.03, p = 4.25 × 10-8; β = 0.03, p = 3.97 × 10-8) than males (β = - 0.02, p = 0.009; β = 0.01, p = 0.20). Higher levels of expression of SERPINB1, SERPINB6, and SERPINB9 in PFC was associated with higher levels of amyloidosis among females (corrected p values < 0.02) but not males (p > 0.38). In total tau, we observed a sex interaction at a previous locus, rs1393060 proximal to GMNC (p = 0.004), driven by a stronger association among females (β = 0.05, p = 4.57 × 10-10) compared to males (β = 0.02, p = 0.03). There was also a sex-specific association between rs1393060 and tangle density at autopsy (pfemale = 0.047; pmale = 0.96), and higher levels of expression of two genes within this locus were associated with lower tangle density among females (OSTN p = 0.006; CLDN16 p = 0.002) but not males (p ≥ 0.32). Results suggest a female-specific role for SERPINB1 in amyloidosis and for OSTN and CLDN16 in tau pathology. Sex-specific genetic analyses may improve understanding of AD's genetic architecture.
Keywords: APOE; Alzheimer disease; Amyloid; Cerebrospinal fluid biomarkers; Neuropathology; Sex difference; Tau.
Conflict of interest statement
Competing Financial Interests
Figures




Similar articles
-
Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau.JAMA Neurol. 2018 Aug 1;75(8):989-998. doi: 10.1001/jamaneurol.2018.0821. JAMA Neurol. 2018. PMID: 29801024 Free PMC article.
-
Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.Acta Neuropathol. 2017 May;133(5):839-856. doi: 10.1007/s00401-017-1685-y. Epub 2017 Feb 28. Acta Neuropathol. 2017. PMID: 28247064 Free PMC article.
-
Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.BMC Neurol. 2010 Oct 8;10:90. doi: 10.1186/1471-2377-10-90. BMC Neurol. 2010. PMID: 20932310 Free PMC article.
-
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.Neuron. 2013 Apr 24;78(2):256-68. doi: 10.1016/j.neuron.2013.02.026. Epub 2013 Apr 4. Neuron. 2013. PMID: 23562540 Free PMC article.
-
Genome-Wide Meta-Analysis of Cerebrospinal Fluid Biomarkers in Alzheimer's Disease and Parkinson's Disease Cohorts.Mov Disord. 2023 Sep;38(9):1697-1705. doi: 10.1002/mds.29511. Epub 2023 Aug 4. Mov Disord. 2023. PMID: 37539664 Free PMC article.
Cited by
-
Intersectionality in Alzheimer's Disease: The Role of Female Sex and Black American Race in the Development and Prevalence of Alzheimer's Disease.Neurotherapeutics. 2023 Jul;20(4):1019-1036. doi: 10.1007/s13311-023-01408-x. Epub 2023 Jul 25. Neurotherapeutics. 2023. PMID: 37490246 Free PMC article. Review.
-
Neuropathological and sociodemographic factors associated with the cortical amyloid load in aging and Alzheimer's disease.Geroscience. 2024 Feb;46(1):621-643. doi: 10.1007/s11357-023-00982-4. Epub 2023 Oct 23. Geroscience. 2024. PMID: 37870702 Free PMC article.
-
Module Analysis Using Single-Patient Differential Expression Signatures Improves the Power of Association Studies for Alzheimer's Disease.Front Genet. 2020 Nov 20;11:571609. doi: 10.3389/fgene.2020.571609. eCollection 2020. Front Genet. 2020. PMID: 33329707 Free PMC article.
-
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.Nat Rev Neurol. 2019 Sep;15(9):501-518. doi: 10.1038/s41582-019-0228-7. Epub 2019 Jul 31. Nat Rev Neurol. 2019. PMID: 31367008 Free PMC article. Review.
-
Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease.Neurobiol Aging. 2020 Sep;93:61-68. doi: 10.1016/j.neurobiolaging.2020.04.025. Epub 2020 Apr 29. Neurobiol Aging. 2020. PMID: 32450446 Free PMC article.
References
-
- Altmann A, Tian L, Henderson VW, Greicius MD, Alzheimer’s Disease Neuroimaging Initiative I (2014) Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol 75: 563–573 10.1002/ana.24135 - DOI - PMC - PubMed
-
- Apostolova LG, Dinov ID, Dutton RA, Hayashi KM, Toga AW, Cummings JL, Thompson PM (2006) 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer’s disease. Brain 129: 2867–2873 10.1093/brain/awl274 - DOI - PubMed
-
- Ataman B, Boulting GL, Harmin DA, Yang MG, Baker-Salisbury M, Yap EL, Malik AN, Mei K, Rubin AA, Spiegel I et al. (2016) Evolution of Osteocrin as an activity-regulated factor in the primate brain. Nature 539: 242–247 10.1038/nature20111 - DOI - PMC - PubMed
-
- Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA (2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62: 685–691 10.1001/archpsyc.62.6.685 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 HG006375/HG/NHGRI NIH HHS/United States
- P50 AG005142/AG/NIA NIH HHS/United States
- R01 AG021155/AG/NIA NIH HHS/United States
- R01 NS080820/NS/NINDS NIH HHS/United States
- P50 AG005133/AG/NIA NIH HHS/United States
- R01 NS100980/NS/NINDS NIH HHS/United States
- P30 AG028383/AG/NIA NIH HHS/United States
- R01 AG015819/AG/NIA NIH HHS/United States
- P30 AG013854/AG/NIA NIH HHS/United States
- P30 AG053760/AG/NIA NIH HHS/United States
- R01 AG037639/AG/NIA NIH HHS/United States
- P50 AG023501/AG/NIA NIH HHS/United States
- U01 AG046152/AG/NIA NIH HHS/United States
- P30 AG010124/AG/NIA NIH HHS/United States
- RF1 AG015819/AG/NIA NIH HHS/United States
- R01 AG054076/AG/NIA NIH HHS/United States
- T32MH014877/MH/NIMH NIH HHS/United States
- R01 AG056534/AG/NIA NIH HHS/United States
- R01 AG044546/AG/NIA NIH HHS/United States
- P30 AG010133/AG/NIA NIH HHS/United States
- U24 AG021886/AG/NIA NIH HHS/United States
- Z99 AG999999/ImNIH/Intramural NIH HHS/United States
- T32 GM080178/GM/NIGMS NIH HHS/United States
- P50 AG005131/AG/NIA NIH HHS/United States
- P50 AG016574/AG/NIA NIH HHS/United States
- P50 AG005146/AG/NIA NIH HHS/United States
- P01 AG017586/AG/NIA NIH HHS/United States
- U01 AG052411/AG/NIA NIH HHS/United States
- R01 AG019085/AG/NIA NIH HHS/United States
- U01 AG032984/AG/NIA NIH HHS/United States
- RF1 AG053303/AG/NIA NIH HHS/United States
- R01 AG030146/AG/NIA NIH HHS/United States
- U01 AG024904/AG/NIA NIH HHS/United States
- P30 AG035982/AG/NIA NIH HHS/United States
- P50 AG008702/AG/NIA NIH HHS/United States
- R01 NS085419/NS/NINDS NIH HHS/United States
- U01 AG016976/AG/NIA NIH HHS/United States
- P01 AG003991/AG/NIA NIH HHS/United States
- P30 AG008051/AG/NIA NIH HHS/United States
- P50 AG005681/AG/NIA NIH HHS/United States
- R01 HL111516/HL/NHLBI NIH HHS/United States
- P30 AG013846/AG/NIA NIH HHS/United States
- P01 AG026276/AG/NIA NIH HHS/United States
- R01 AG017917/AG/NIA NIH HHS/United States
- U19 AG033655/AG/NIA NIH HHS/United States
- R01 AG027161/AG/NIA NIH HHS/United States
- P50 AG005136/AG/NIA NIH HHS/United States
- S10 OD018522/OD/NIH HHS/United States
- P30 AG012300/AG/NIA NIH HHS/United States
- U54 HD083211/HD/NICHD NIH HHS/United States
- RF1 AG051504/AG/NIA NIH HHS/United States
- P50 AG016573/AG/NIA NIH HHS/United States
- U24 AG041689/AG/NIA NIH HHS/United States
- P50 AG016570/AG/NIA NIH HHS/United States
- P50 AG005134/AG/NIA NIH HHS/United States
- R21 AG059941/AG/NIA NIH HHS/United States
- P30 AG008017/AG/NIA NIH HHS/United States
- P30 AG010161/AG/NIA NIH HHS/United States
- RF1 AG059869/AG/NIA NIH HHS/United States
- R03 AG050856/AG/NIA NIH HHS/United States
- R01 AG061796/AG/NIA NIH HHS/United States
- P50 AG025688/AG/NIA NIH HHS/United States
- U01 AG006781/AG/NIA NIH HHS/United States
- S10 OD023680/OD/NIH HHS/United States
- P50 AG005138/AG/NIA NIH HHS/United States
- U01 AG052409/AG/NIA NIH HHS/United States
- U01 AG046139/AG/NIA NIH HHS/United States
- RF1 AG044546/AG/NIA NIH HHS/United States
- K12 HD043483/HD/NICHD NIH HHS/United States
- U01 HG004610/HG/NHGRI NIH HHS/United States
- K01 AG049164/AG/NIA NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
- P30 AG019610/AG/NIA NIH HHS/United States
- R01 AG048015/AG/NIA NIH HHS/United States
- K24 AG046373/AG/NIA NIH HHS/United States
- P50 AG033514/AG/NIA NIH HHS/United States
- R01 AG034962/AG/NIA NIH HHS/United States
- IK2 BX001820/BX/BLRD VA/United States
- R01 AG035083/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous